A busy start to 2019

 

The first few weeks of 2019 have flown by here at Maverex, and with February fast approaching we’d like to share some of the things we’re looking forward to in the coming months:

  • New and improved eGVD products
    We’re continually tweaking our eGVD and Value Story online and app-based platforms based on our (and our clients) experience using them. Over the last few months we’ve been busy working on exciting updates to optimise usability, add innovative new features, and keep the design fresh. Please contact us for a showcase of our new demo!
  • New interactive ‘R’ health economic model templates
    Our team are working hard on developing user-friendly interactive health-economic model templates in R. Our templates allow all users to rapidly test cost-effectiveness scenarios for early stage products using target product profile data. No modelling capability is required to use our template models as they have an easy to use, intuitive, interface. They can also be used as a basis for building HTA ready models. Please contact us for a demo of our survival template model.  
  • PPMA Congress March 2019
    The Maverex team are really looking forward to the Pharma Pricing & Market Access Congress in Amsterdam this March. It’s Europe’s leading pricing, market access and evidence congress for the Biopharma industry, with a focus on innovative practices as well as expanding on developments in rare diseases, advanced therapies and emerging markets. So it’s right up our street, and we’re excited to see what we will learn this year. If you’re planning on attending do let us know, we’d love to catch up
  • New research publications
    Watch this space for details on several systematic review manuscripts currently in preparation for publication this year
  • Our growing team
    We’re delighted that Maverex is growing, as new experienced team members join us, enhancing our skill base and allowing us to work on more exciting projects in 2019. We have recently welcomed new team members to both our systematic review and modelling teams.

We hope you’ve also had a productive start to the year, and would love to hear from you if you’d like to know more about anything mentioned above (enquiries@maverex.com)